MTX-211
MTX-211 is a dual inhibitor targeting EGFR and PI3K, utilized in cancer research. It has demonstrated activity in both in vitro cell-based assays and in vivo tumor models, supporting its investigation in oncology and related disease pathways.
Product Specifications
CAS Number
1952236-05-3
Product Name Alternative
Cancer, MTX 211, MTX211, MTX-211, inhibit, Mol 211, Mol211, Mol-211, Epidermal growth factor receptor, ErbB-1, EGFR, Inhibitor, HER1, PI3K, phosphoinositide 3 ' OH kinase family (PIK3), Phosphoinositide 3-kinase, quinazoline derivatives, the epidermal growth factor EGFR family
Field of Research
Cardiovascular Research, Signal Transduction
Purity
97.28% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.09 mM) ; DMSO:15 mg/mL (31.36 mM)
Smiles
CS (=O) (=O) Nc1cc (cnc1Cl) -c1ccc2ncnc (Nc3ccc (F) c (Cl) c3) c2c1
Molecular Formula
C20H14Cl2FN5O2S
Molecular Weight
478.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
